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Abstract
The evaluation of telemedicine can be achieved using different evaluation models or theoretical frameworks. This paper
presents a scoping review of published studies which have applied the Model for Assessment of Telemedicine (MAST).
MAST includes pre-implementation assessment (e.g. by use of participatory design), followed by multidisciplinary assessment,
including description of the patients and the application and assessment of safety, clinical effectiveness, patient perspectives,
economic aspects organisational aspects and socio-cultural, legal and ethical aspects. Twenty-two studies met the inclusion
criteria and were included in the review. In this article, research design and methods used in the multidisciplinary assessment are
described, strengths and weaknesses are analysed, and recommendations for future research are presented.
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Introduction
Investment in telemedicine requires evidence to support
the value and expected beneﬁts from the perspective of
the patient and health service provider. The evaluation
of telemedicine can be achieved using a range of diﬀerent
evaluation models or theoretical frameworks.1 Whilst
these frameworks serve as useful guides, it seems that
none have been used extensively.
The Model for Assessment of Telemedicine (MAST) is
one evaluation framework which focuses on the measure-
ment of eﬀectiveness and quality of care. In this context,
the MAST represents a multidisciplinary process, evaluat-
ing the medical, social, economic, and ethical aspects of
telemedicine in a systematic, unbiased, robust manner.2
This statement of principle is based on the deﬁnition of
health technology assessment (HTA) in the EUnetHTA
project.3
The use of MAST includes three steps as described
in Figure 1. In the preceding assessment (Step 1) the
maturity of the telemedicine technology and the organisa-
tion using the service is assessed before the assessment
of eﬀectiveness is carried out. If the maturity of the tech-
nology needs to be developed further formative studies
including participatory design (PD) studies, usability
studies or feasibility studies must be carried out. Similar
optimisation studies can be used to mature and
develop the organisation using the telemedicine service.
Following implementation, a multidisciplinary assessment
(Step 2) of the eﬀectiveness of the technology can be car-
ried out using MAST. MAST encompasses seven domains
including identiﬁcation of the health problem and charac-
teristics of the application; safety; clinical eﬀectiveness;
patient perspectives; economic aspects; organisational
aspects; and socio-cultural, ethical and legal aspects.
Recently the face validity of the content of these seven
domains has been conﬁrmed in a Delphi process.4
Finally, an assessment should be made of the transferabil-
ity of the results (Step 3) reported in studies concerning the
previous steps.
The aim of this paper is to review published studies
which have used MAST for any of the seven domain
areas. We have summarised the methods and research
designs used for data collection, lessons learned, and
considerations for further research. We hope that this
information is useful for researchers and clinicians
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planning to use MAST for the assessment of new tele-
medicine applications.
Methods
The scoping review was carried out using the Arksey and
O’Malley framework.5 Scoping review is a rapid form of
knowledge synthesis where the aim is to map the key con-
cepts underpinning a research area and the main sources
of evidence available. It diﬀers from a systematic review
by addressing broader research questions, permitting
inclusion of diﬀerent study designs, not assessing the qual-
ity of the included studies, having a less structured data
extraction, and typically using a qualitative synthesis of
the evidence.5 The scoping review included papers which
explicitly reported on the use of MAST.
Research question
The research question in this review is: what are the lessons
learned from the empirical studies of telemedicine based on
MAST and which aspects require further research?
Eligibility criteria
We included studies that used the ﬁrst step of MAST (i.e.
the preceding assessment) or studies of the eﬀectiveness
and consequences of telemedicine (i.e. the multidisciplin-
ary assessment). Studies were included if they described
MAST as part of the basis for the design of the study of a
telemedicine application. In addition, PD studies of tele-
medicine known to the authors are included because they
form the basis for development of new types of telemedi-
cine tested in ongoing studies based on MAST. Articles
were included if they were published in the English lan-
guage and in peer-reviewed journals from January 2013 to
March 2017. Publications describing MAST as part of a
description of research methods in telemedicine in general
were excluded.
Search and screening
Relevant articles were identiﬁed by searching the Medline
database and Google scholar using the search strategy:
MAST AND (telemedicine OR telehealth OR ehealth
OR mhealth).
Hereafter, citations of the ﬁrst article describing
MAST2 in Medline and Google Scholar were reviewed.
Initially, the titles and abstracts identiﬁed from the
literature search were screened for empirical studies of
telemedicine applications. The full text of the potentially
relevant studies were obtained for assessment of eligibility
and examined in order to identify descriptions of their
use of MAST. This information is rarely available in the
abstract and required careful examination of the full text.
The search was done by the lead author and papers were
subsequently reviewed by all investigators. Discussion
amongst the authors led to the analysis of all papers iden-
tiﬁed in the search.
Data extraction
The following data were collected from the included stu-
dies: primary author, year of publication, country in
which the study took place, intervention, patient group,
study design, domains included and primary outcomes,
protocol or reporting of results.
Analysis and reporting
We categorised the studies based on geographical distri-
bution, the telemedicine interventions, and patient groups.
Further, the study design and outcome measures including
assessment of the clinical outcomes, patient perceptions,
economic aspects, and organisational aspects were ana-
lysed, with a focus on the lessons learned and the need
for additional research. The analysis and reporting focus
on these four domains because they are most frequent in
the studies of telemedicine based on MAST. Findings are
reported narratively.
Results
The PubMed and Google Scholar search resulted in
10 and 1240 publications, respectively. In addition, 22
and 124 citations of the ﬁrst description of MAST2
were found in the two databases. Screening of abstracts
and full-text articles resulted in 22 publications6-27
being included in this review (Figure 2). A large
number of citations of MAST were excluded because
the articles were guidelines or reviews of the tool and
models for evaluation, assessment or implementation of
telemedicine and health information technology (IT),
describing MAST as one of several models as an
example.28-30
Studies were published between 2013 and 2017 and the
telemedicine intervention took place in 12 European coun-
tries (Table 1). Most frequent are studies from Denmark
(n¼10) and Norway (n¼7), reﬂecting that MAST was
STEP 2: Multidisciplinary assessment:
1. Health problem and characteristics of the application  
2. Safety 
3. Clinical effectiveness 
4. Patient perspectives
5. Economic aspects
6. Organisational aspects 
7. Socio-cultural, ethical and legal aspects
STEP 1: Preceding assessment:
• Purpose of the telemedicine application?
• Are the technology and the organization matured?
STEP 3: Transferability assessment:
• Cross-border
• Scalability
• Generalizability
Figure 1. The three steps in Model for Assessment of
Telemedicine.
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originally developed by researchers from Denmark,
Norway, and Scotland. The majority (n¼16) of the tele-
medicine interventions were home monitoring of patients
with chronic disease (e.g. diabetes, chronic obstructive
pulmonary disease (COPD) or heart disease). The remain-
ing studies include patients with obesity, patients with
limited access to care, parents using neonatal home care
and support of early post-natal discharge. Thirteen studies
are based on randomised controlled trials (RCTs), and
other studies include observational studies, interview stu-
dies, pilot studies, and feasibility studies. Five publications
describe protocols, the rest describe results from studies.
Domains and outcomes measures included are described
in detail below. A number of publications were based on
the same study – for example, three publications described
the clinical results,22 the economic aspects,13 and the
organisational aspects23 of telemedicine intervention for
patients with diabetic foot ulcers. This study was also
part of the European Renewing Health project and was
similar to six other studies.10,12,17,24-26
Methods used in preceding assessment
One approach used for the development of new telemedi-
cine interventions involves PD. Two examples are
described in Table 1,9,14 where PD was used in the devel-
opment and design of interventions that were assessed by
use of MAST. The use of PD in ﬁrst step of MAST (the
preceding assessment) has also been described.4 The aim of
PD is to develop technical systems in close and genuine
cooperation with end users. An important requirement is
not only to bring users into the laboratory setting, but also
to bring researchers out into the ﬁeld to observe, to ask
questions, and to better understand the requirements.31
PD is a multifaceted process, as the project can change
continuously throughout the project period between ana-
lyses, design, and development.32
The research process starts in Phase 1 with a clinical or
organisational problem you want to explore with identi-
ﬁed stakeholders. The researchers then carry out a litera-
ture review and ﬁeld studies. Getting a grip on problems
and challenges, interviews and focus groups are performed
to get the stakeholders’ direct view. The next step includes
user activities and creative workshops. The aim of the
workshops is to reveal problems and visions about solu-
tions in the focus area. In studies of telemedicine, the
workshops have revealed new knowledge regarding the
clinical problem that had not been captured by interviews
and focus groups.33,34 The next step is the development
Phase 2, where the ﬁrst prototype is developed, modiﬁed,
Figure 2. Flow diagram of search and screening of articles.
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and re-tested until the prototype is ready for the ﬁnal pilot
test.35 Often, testing in the real world presents new chal-
lenges not originally seen in a testing environment.35,36
In Phase 3, the technology is tested in a real-life setting,
for patients receiving clinical care. Successful examples of
this process have been reported for telemedicine or tele-
health strategies involving discharge planning and out-
patient care of patients with chronic health conditions.35,36
The studies described show that PD is a suitable research
design for the planning and implementation of telemedi-
cine. Based on the studies of telemedicine we have learned
that PD facilitates changes in the organisation and in its
culture, and creates solutions and organisational changes
required for implementation. The PD process relies on
qualitative methods and is useful for engaging with stake-
holders and encouraging ownership of the project.
Methods used in multidisciplinary assessment
Assessment of safety and clinical outcomes. In the current
study we identiﬁed 16 journal articles and seven project
reports that assessed the clinical eﬀectiveness domain as
part of the multidisciplinary assessment of telemedicine.
Eleven journal articles reported the results of telemedicine
interventions, and the remaining ﬁve articles were study
protocols.
A number of outcome measures for studies of clinical
eﬀectiveness have been suggested in the MAST manual.37
These include quality of life, health status, biometric
measurement (e.g. HbA1c, weight, blood pressure), and
health service utilisation (e.g. number of hospitalisations,
number of clinic visits and number of emergency depart-
ment presentations). The instruments and biometric meas-
urements suggested in the MAST manual do not comprise
an exhaustive list, and there exist many validated instru-
ments and clinically relevant biometric measurements
that could be used to assess clinical eﬀectiveness of the
telemedicine intervention. In the included articles these
constructs have been measured using generic health-
related quality of life instruments (e.g. SF-36,38
Manchester short assessment of quality of life39) or
disease-speciﬁc instruments (e.g. St George’s respiratory
questionnaire40 or the Clinical COPD Questionnaire.41).
The biometric measurements are typically those that would
be used in clinical practice. Service utilisation is typically
extracted from databases used in clinical practice.
Eleven of the included empirical studies used a RCT
study design. One criticism of RCTs is that they measure
the eﬃcacy of a telemedicine intervention as opposed to
the eﬀectiveness. This is due to the controlled environment
in which they sometimes operate, rather than the real
world needed to measure eﬀectiveness. Hence, clinical
eﬀectiveness may be better assessed using longer study
periods, alternative study designs, for example prospective
cohort study and performing the study only when the tele-
medicine intervention has normalised into everyday prac-
tice. On the other hand, the internal validity of these
studies may be lower because of a higher risk of biasT
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that cannot always be controlled for. This does not pre-
clude the need to perform RCTs to provide evidence sup-
porting the normalisation of a telemedicine intervention.
There are a number of authors that support the ideals
of multidisciplinary assessment such as MAST and sug-
gest there is value in including complementary qualitative
studies investigating perception and experience to any
assessment of clinical eﬀectiveness.42,43 This can be
achieved by bundling the MAST domains of clinical
eﬀectiveness, patient perspectives and organisational
aspects. The patients and the staﬀ’s perception of a new
telemedicine may have an eﬀect on the clinical outcomes.
Thus, in order to understand why an expected clinical
outcome was achieved or not, ﬁndings in the patient and
the organisational domain could be of high value. Thus,
researchers should ensure complementary analysis of clin-
ical, patient perspective, and organisational aspects to give
a more comprehensive understanding of telemedicine
interventions.
Assessment of patient perception. Thirteen studies include
assessment of outcomes with the fourth domain of patient
perception (Table 1). Most studies used general terms
like user perception, user perspectives or patient experi-
ence when describing the outcome measures included.
A number of studies (n¼3) used validated questionnaires
such as the Service User Technology Acceptability
Questionnaire (SUTAQ)10 and the System Usability
Scale (SUS). SUTAQ includes 22 questions regarding
patient acceptability of telemedicine, and based on the
answers six acceptability scales can be estimated. The pre-
dictive validity of the instrument was recently conﬁrmed.44
SUS is a simple scale for usability test of IT systems
including 10 questions with ﬁve response options.45 It is
technology independent and has been tested on technolo-
gies such as hardware, consumer software, websites, cell-
phones etc., and the validity has been demonstrated by
comparison with more extensive usability scales.46
Both questionnaires and personal interviews have been
used to assess patient perception. The advantage of inter-
views is the possibility of gaining a better understanding
of the perception of the telemedicine service by the indi-
vidual patient. On the other hand, questionnaires have
the advantage of being able to collect information about
the perception of a telemedicine service by a large number
of patients. Further, questionnaires oﬀer the possibility of
combining the results in a simple, quantitative measure
that can compare the patients’ view of other telemedicine
services. A further option is use both quantitative
and qualitative methods (i.e. mixed methods) to gain a
comprehensive understanding of a telemedicine interven-
tion. Mixed-method techniques in telemedicine have been
described elsewhere.47
Information about patients’ perception and acceptabil-
ity of telemedicine is still limited. This is a problem
because even though patients are involved in the develop-
ment of new technologies, for example by use of PD,
patients’ acceptance of telemedicine may vary – for
example, 34% of the patients in the Italian part of the
Review Health project declined to participate.10
Hopefully it will be possible in the future to combine
many studies of patients’ perception of telemedicine and
ﬁnd an average level of acceptability with which new tech-
nologies can be compared. Similarly, there is a need for
more research to identify patient groups with a lower than
average degree of acceptability in order to be able to pre-
dict important factors (such as patient characteristics and
resource requirements10) which may help improve the
uptake of new telehealth services.
Assessment of economic aspects. Nine studies include a
description of assessment of the economic aspects of tele-
medicine (Table 1). Of these, three are protocols and six
report results from studies. Most studies claim to have
done a cost-eﬀectiveness analysis with estimation of the
eﬀect of telemedicine on the mean costs per patient from a
healthcare or societal point of view, and one study calcu-
lates the business case for the hospital implementing the
telemedicine service.20
MAST describes2 that reporting of results should follow
guidelines for reporting of health research and recommends
a speciﬁc guideline for economic evaluation.48 According to
this detailed information about data collection, impact on
quantities (e.g. number of contacts and admissions), prices,
and statistical analysis should all be reported. Only one of
the nine studies followed this guideline.13 Most studies do
not give detailed information about the economic analysis,
but include information about the economic aspects as a
section in the overall discussion of the results. This lack of
quality in the reporting of economic evaluations of tele-
medicine is a general problem for studies of telemedicine,
as described in a number of reviews.49,50
The studies that form the basis for the assessment of
the economic aspects are generally based on RCTs.
The main argument for RCTs is that this design has a
high level of internal validity because it minimises the
risk of systematic error (bias) by ensuring that the inter-
vention and the control groups are similar in terms of
both observed and unobserved characteristics. However,
this may be at the expense of a low degree of transferabil-
ity or external validity.51 For example, if only highly moti-
vated patients were included in a RCT in order to get a
high level of compliance, the level of transferability of the
results may be low. Similarly, if expensive IT solutions
are used to improve engagement of patients and health
professionals and thereby increase the success of the
trial, it may end up making the home monitoring solution
more costly than otherwise needed.
Therefore, economic evaluations of telemedicine
can improve both by following guidelines for data collec-
tion and reporting of economic evaluations and by con-
sidering the economic consequence of selecting the speciﬁc
research design. If the use of a randomised design in itself
may increase the mean costs per patient, then alternative
designs, such as observational studies or prospective
cohort studies, need to be considered.
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Assessment of organisational aspects. The implementation
of telemedicine may introduce major organisational
changes.52 These changes include process change
(e.g. workforce, staﬀ training and resources, interaction,
communication, task shifting), structural change (e.g. geo-
graphic spread), or cultural changes (e.g. culture, attitude,
and management).2 As a result, investigation of organisa-
tional aspects is included as a domain in the multidiscip-
linary MAST framework.
In the current study, we identiﬁed 10 peer-reviewed
journal articles and one conference abstract that assessed
the organisational aspects of a telemedicine intervention.
Six journal articles published results from pragmatic
analysis of actual telemedicine interventions, and the
remaining ﬁve articles were protocol papers. Many of
the published papers that conducted organisational ana-
lysis did so through the experience of the healthcare pro-
fessional, or through the perception of the healthcare
professional involved in the telemedicine intervention.
A combination of healthcare professionals’ experience
and perception were used in a number of studies.6,16,18
For example, Lamprinos et al.18 explored healthcare pro-
fessionals’ experiences with workﬂow and eﬃciency
consequences of managing patient using ICT-based inter-
ventions for diabetes self-management, and further
explored the healthcare professionals’ perceptions on the
potential eﬃciency consequences in the mid-to-long term.
A group of constructs to investigate organisational
aspects have been suggested in the MAST manual – for
example, number of patients treated, referral times,
changes in the number of staﬀ resulting from the telemedi-
cine intervention, changes in the number of face-to-face
consultations, changes in the way members of the health-
care team communicate.37 These constructs have been
used with a high degree of ﬁdelity in a number of included
studies.8,16,23 A number of studies introduce variations
and new constructs – for example, job satisfaction,16
facilitators and barriers of the telemedicine interven-
tional,24 and organisational restructuring.21 Qualitative
study design has been used to investigate organisational
aspects in many of the included articles.6,16,18,20,21,23,24
Typically, these studies collect data via qualitative inter-
views or focus groups with clinicians.
It would appear that rigorous qualitative methods have
not been used in many of the evaluations in this domain.
Notably, the small numbers of participants used in quali-
tative interview and focus groups are unlikely to have
reached data saturation, analysis of data does not appear
to use established methods (e.g. content analysis, thematic
analysis), and reporting does not meet established guide-
lines (e.g. consolidated criteria for reporting qualitative
research [COREQ]53). Addressing these issues may improve
the quality of the evaluation in this domain. However, it
remains to be seen if improved reporting can be achieved
given restrictive word counts in many journals.47 As previ-
ously discussed a number of authors, for example Vis
et al.,27 have used validated survey instruments, for exam-
ple SUS,45 to assess healthcare professionals’ perception
and experience. However, other reports just describe that
they have been using questionnaires ‘based on MAST’
without further information about content or validity of
questionnaires.8 Development of validated instruments
for assessment of the perception of telemedicine would
improve both the consistency and quality of research in
the domain. A further limitation of the assessment of
organisational aspects from the included studies is that gen-
eralisability of ﬁndings is diﬃcult due to wide variation in
services and contexts. To facilitate naturalistic generalisa-
tion which relies on a ‘context dependant judgment of ﬁt’54
between services, inclusion of MAST’s health problem and
characteristics of the intervention should be included in
studies that assess organisational aspects.
Limitations
The aim of this scoping review was not to evaluate the
quality of the evidence, but rather to give an overview of
the literature on MAST evaluations, and to identify
potential research gaps. This review focuses on one spe-
ciﬁc assessment model, which does mean that other frame-
works are excluded. We also acknowledge that MAST is
relatively new, and therefore in time we expect to gain a
clearer insight into its application and potential value in
telehealth research.
Conclusion
This scoping review describes the uptake of MAST in the
assessment of telemedicine applications, summarises the
reported methods and research designs, and suggests areas
for further research. The MAST multidisciplinary assess-
ment oﬀers the opportunity to assess a telemedicine appli-
cation in seven domains; however, most of the included
articles describe results within a single MAST domain.
Researchers may focus on individual domains in articles
dependingon the researchquestion and theword count limi-
tations set by speciﬁc journals; however, it is recommended
that, where possible, MAST is applied as a complete frame-
work. Data collection in many of the included studies is
often based onRCTs; in some cases thismay be problematic
because clinical, economic or organisational aspects are not
fully included. Further, because of compliance issues with
guidelines for reporting economic and organisational stu-
dies, generalisability is limited. This review paper highlights
a need for more validated instruments for the evaluation of
user experience and organisational eﬀect; and more robust
mixed methods to assess the MAST domains.
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